Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate

9 Jan 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Long-Term Effects of COVID-19
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36624276
DOI: 10.1038/s41593-022-01242-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidatePMID 36624276Read ↗

Brain cross‐protection against SARS‐CoV‐2 variants by a lentiviral vaccine in new transgenic miceSemantic proximity Read ↗

The challenge of emerging SARS-CoV-2 mutants to vaccine development.Semantic proximity Read ↗

A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidateSemantic proximity Read ↗

Environmental exposures and familial background alter the induction of neuropathology and inflammation after SARS-CoV-2 infectionSemantic proximity Read ↗

Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2Semantic proximity Read ↗

Full Brain and Lung Prophylaxis against SARS-CoV-2 by Intranasal Lentiviral Vaccination in a New hACE2 Transgenic Mouse Model or Golden HamstersSemantic proximity Read ↗

Brain and Lung Cross-Protection against Ancestral or Emerging SARS-CoV-2 by Intranasal Lentiviral Vaccination in a New hACE2 Transgenic Murine ModelSemantic proximity Read ↗

Mouse Adapted SARS-CoV-2 (MA10) Viral Infection Induces Neuroinflammation in Standard Laboratory MiceSemantic proximity Read ↗

Evaluating Antibody Mediated Protection against Alpha, Beta, and Delta SARS-CoV-2 Variants of Concern in K18-hACE2 Transgenic MiceSemantic proximity Read ↗

Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal modelsSemantic proximity Read ↗

Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaquesSemantic proximity Read ↗

Reduced SARS-CoV-2 mRNA vaccine immunogenicity and protection in mice with diet-induced obesity and insulin resistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.